[Form 4] Elanco Animal Health Incorporated Insider Trading Activity
Elanco Animal Health insider transaction: The Form 4 reports that Rajeev A. Modi, Executive Vice President U.S. Pet Health and Global Digital Transformation, was granted 78.9849 deferred stock units on 08/22/2025. Each deferred stock unit represents the right to receive one share of Elanco common stock or a cash equivalent. The filing shows an exercise/reference price of $17.91 and indicates Mr. Modi beneficially owns 6,814.29 shares (or units) following the reported transaction. The deferred units will settle in cash or shares following termination of employment or in a specified future year under the company鈥檚 Executive Deferral and Stock Match Plan.
Operazione interna di Elanco Animal Health: Il Modulo 4 segnala che Rajeev A. Modi, Vicepresidente esecutivo U.S. Pet Health e Global Digital Transformation, ha ricevuto in data 22/08/2025 78,9849 unit脿 azionarie differite. Ogni unit脿 differita d脿 diritto a ricevere una azione ordinaria di Elanco o l'equivalente in contanti. La comunicazione riporta un prezzo di esercizio/riferimento di $17,91 e indica che il signor Modi detiene beneficiariamente 6.814,29 azioni (o unit脿) dopo l'operazione. Le unit脿 differite verranno liquidate in contanti o in azioni al termine del rapporto di lavoro o in un anno futuro specificato, in base all'Executive Deferral and Stock Match Plan della societ脿.
Transacci贸n interna de Elanco Animal Health: El Formulario 4 informa que Rajeev A. Modi, Vicepresidente Ejecutivo de U.S. Pet Health y Global Digital Transformation, recibi贸 el 22/08/2025 78,9849 unidades accionarias diferidas. Cada unidad diferida otorga el derecho a recibir una acci贸n ordinaria de Elanco o su equivalente en efectivo. La presentaci贸n muestra un precio de ejercicio/referencia de $17.91 e indica que el Sr. Modi posee beneficiariamente 6,814.29 acciones (o unidades) tras la transacci贸n. Las unidades diferidas se liquidar谩n en efectivo o en acciones al t茅rmino del empleo o en un a帽o futuro especificado conforme al Executive Deferral and Stock Match Plan de la compa帽铆a.
Elanco Animal Health 雮措秬 瓯半灅: Form 4鞐� 霐半ゴ氅� Rajeev A. Modi(氙戈淡 韼� 項姢 氚� 旮�搿滊矊 霐旍韯� 鞝勴櫂 雼措嫻 靾橃劃 攵�靷灔)電� 2025-08-22鞐� 78.9849 歆�鞐� 欤检嫕 雼渼毳� 攵�鞐皼鞎橃姷雼堧嫟. 臧� 歆�鞐� 欤检嫕 雼渼電� Elanco 氤错喌欤� 1欤� 霕愲姅 順勱笀 靸侅潙鞎§潉 氚涭潉 甓岆Μ毳� 鞚橂頃╇媹雼�. 鞝滌稖靹滊鞐愲姅 頄夓偓臧�/旮办臧�瓴╈澊 $17.91搿� 旮办灛霅橃柎 鞛堨溂氅�, 氤搓碃霅� 瓯半灅 頉� Modi 鞌皜 6,814.29欤�(霕愲姅 雼渼)毳� 鞁れ鞝侅溂搿� 氤挫湢頃橁碃 鞛堧姅 瓴冹溂搿� 響滌嫓霅橃柎 鞛堨姷雼堧嫟. 鞚� 歆�鞐� 雼渼電� 瓿犾毄 膦呺 鞁滌爯 霕愲姅 須岇偓鞚� Executive Deferral and Stock Match Plan鞐� 霐半澕 歆�鞝曤悳 頄ロ泟 鞐半弰鞐� 順勱笀 霕愲姅 欤检嫕鞙茧 鞝曥偘霅╇媹雼�.
Transaction interne d'Elanco Animal Health : Le formulaire 4 indique que Rajeev A. Modi, vice鈥憄r茅sident ex茅cutif U.S. Pet Health et Global Digital Transformation, s'est vu attribuer le 22/08/2025 78,9849 unit茅s d'actions diff茅r茅es. Chaque unit茅 diff茅r茅e donne le droit de recevoir une action ordinaire d'Elanco ou l'茅quivalent en esp猫ces. Le dossier mentionne un prix d'exercice/de r茅f茅rence de 17,91 $ et pr茅cise que M. Modi d茅tient b茅n茅ficiairement 6 814,29 actions (ou unit茅s) apr猫s la transaction d茅clar茅e. Les unit茅s diff茅r茅es seront r茅gl茅es en esp猫ces ou en actions 脿 la cessation de l'emploi ou au cours d'une ann茅e future sp茅cifi茅e, conform茅ment au Executive Deferral and Stock Match Plan de la soci茅t茅.
Interner Vorgang bei Elanco Animal Health: Das Formular 4 meldet, dass Rajeev A. Modi, Executive Vice President U.S. Pet Health and Global Digital Transformation, am 22.08.2025 78,9849 aufgeschobene Aktieneinheiten erhalten hat. Jede aufgeschobene Einheit berechtigt zum Erhalt einer Aktie der Elanco-Stammaktien oder eines Barwert盲quivalents. Die Einreichung weist einen Aus眉bungs-/Referenzpreis von $17,91 aus und gibt an, dass Herr Modi nach der gemeldeten Transaktion 6.814,29 Aktien (oder Einheiten) wirtschaftlich besitzt. Die aufgeschobenen Einheiten werden bei Beendigung des Arbeitsverh盲ltnisses oder in einem im Executive Deferral and Stock Match Plan der Gesellschaft festgelegten k眉nftigen Jahr in bar oder in Aktien abgewickelt.
- Grant aligns executive pay with shareholder outcomes via deferred stock units that convert to shares or cash
- Clear disclosure of transaction date (08/22/2025), number of units (78.9849), price reference ($17.91), and post-transaction beneficial ownership (6,814.29)
- None.
Insights
TL;DR: Insider received ~79 deferred stock units, modestly increasing beneficial holdings to 6,814.29 units at a reference price of $17.91.
The grant of 78.9849 deferred stock units to a senior executive is a routine compensation event reflecting long-term incentive design rather than open-market buying or selling. The units convert to one share each (or cash) and expand the reporting person鈥檚 beneficial position to 6,814.29 units. From a shareholder perspective, this is an administrative equity-based compensation action tied to the Executive Deferral and Stock Match Plan and does not represent immediate dilution from an open-market issuance disclosed here.
TL;DR: This is a standard deferred compensation grant under an executive plan; it signals alignment with long-term pay practices.
The filing documents a deferred stock unit award that will settle in cash or shares per plan terms, which is consistent with common executive compensation frameworks that defer immediate equity delivery. The disclosure is clear about settlement mechanics and reporting the post-transaction beneficial ownership. No departures from standard governance disclosure practices are evident in the filing itself.
Operazione interna di Elanco Animal Health: Il Modulo 4 segnala che Rajeev A. Modi, Vicepresidente esecutivo U.S. Pet Health e Global Digital Transformation, ha ricevuto in data 22/08/2025 78,9849 unit脿 azionarie differite. Ogni unit脿 differita d脿 diritto a ricevere una azione ordinaria di Elanco o l'equivalente in contanti. La comunicazione riporta un prezzo di esercizio/riferimento di $17,91 e indica che il signor Modi detiene beneficiariamente 6.814,29 azioni (o unit脿) dopo l'operazione. Le unit脿 differite verranno liquidate in contanti o in azioni al termine del rapporto di lavoro o in un anno futuro specificato, in base all'Executive Deferral and Stock Match Plan della societ脿.
Transacci贸n interna de Elanco Animal Health: El Formulario 4 informa que Rajeev A. Modi, Vicepresidente Ejecutivo de U.S. Pet Health y Global Digital Transformation, recibi贸 el 22/08/2025 78,9849 unidades accionarias diferidas. Cada unidad diferida otorga el derecho a recibir una acci贸n ordinaria de Elanco o su equivalente en efectivo. La presentaci贸n muestra un precio de ejercicio/referencia de $17.91 e indica que el Sr. Modi posee beneficiariamente 6,814.29 acciones (o unidades) tras la transacci贸n. Las unidades diferidas se liquidar谩n en efectivo o en acciones al t茅rmino del empleo o en un a帽o futuro especificado conforme al Executive Deferral and Stock Match Plan de la compa帽铆a.
Elanco Animal Health 雮措秬 瓯半灅: Form 4鞐� 霐半ゴ氅� Rajeev A. Modi(氙戈淡 韼� 項姢 氚� 旮�搿滊矊 霐旍韯� 鞝勴櫂 雼措嫻 靾橃劃 攵�靷灔)電� 2025-08-22鞐� 78.9849 歆�鞐� 欤检嫕 雼渼毳� 攵�鞐皼鞎橃姷雼堧嫟. 臧� 歆�鞐� 欤检嫕 雼渼電� Elanco 氤错喌欤� 1欤� 霕愲姅 順勱笀 靸侅潙鞎§潉 氚涭潉 甓岆Μ毳� 鞚橂頃╇媹雼�. 鞝滌稖靹滊鞐愲姅 頄夓偓臧�/旮办臧�瓴╈澊 $17.91搿� 旮办灛霅橃柎 鞛堨溂氅�, 氤搓碃霅� 瓯半灅 頉� Modi 鞌皜 6,814.29欤�(霕愲姅 雼渼)毳� 鞁れ鞝侅溂搿� 氤挫湢頃橁碃 鞛堧姅 瓴冹溂搿� 響滌嫓霅橃柎 鞛堨姷雼堧嫟. 鞚� 歆�鞐� 雼渼電� 瓿犾毄 膦呺 鞁滌爯 霕愲姅 須岇偓鞚� Executive Deferral and Stock Match Plan鞐� 霐半澕 歆�鞝曤悳 頄ロ泟 鞐半弰鞐� 順勱笀 霕愲姅 欤检嫕鞙茧 鞝曥偘霅╇媹雼�.
Transaction interne d'Elanco Animal Health : Le formulaire 4 indique que Rajeev A. Modi, vice鈥憄r茅sident ex茅cutif U.S. Pet Health et Global Digital Transformation, s'est vu attribuer le 22/08/2025 78,9849 unit茅s d'actions diff茅r茅es. Chaque unit茅 diff茅r茅e donne le droit de recevoir une action ordinaire d'Elanco ou l'茅quivalent en esp猫ces. Le dossier mentionne un prix d'exercice/de r茅f茅rence de 17,91 $ et pr茅cise que M. Modi d茅tient b茅n茅ficiairement 6 814,29 actions (ou unit茅s) apr猫s la transaction d茅clar茅e. Les unit茅s diff茅r茅es seront r茅gl茅es en esp猫ces ou en actions 脿 la cessation de l'emploi ou au cours d'une ann茅e future sp茅cifi茅e, conform茅ment au Executive Deferral and Stock Match Plan de la soci茅t茅.
Interner Vorgang bei Elanco Animal Health: Das Formular 4 meldet, dass Rajeev A. Modi, Executive Vice President U.S. Pet Health and Global Digital Transformation, am 22.08.2025 78,9849 aufgeschobene Aktieneinheiten erhalten hat. Jede aufgeschobene Einheit berechtigt zum Erhalt einer Aktie der Elanco-Stammaktien oder eines Barwert盲quivalents. Die Einreichung weist einen Aus眉bungs-/Referenzpreis von $17,91 aus und gibt an, dass Herr Modi nach der gemeldeten Transaktion 6.814,29 Aktien (oder Einheiten) wirtschaftlich besitzt. Die aufgeschobenen Einheiten werden bei Beendigung des Arbeitsverh盲ltnisses oder in einem im Executive Deferral and Stock Match Plan der Gesellschaft festgelegten k眉nftigen Jahr in bar oder in Aktien abgewickelt.
FAQ
What insider transaction did Rajeev A. Modi report on Form 4 for ELAN?
What does each deferred stock unit represent in the ELAN filing?
At what reference price are the deferred stock units reported?
When will the deferred stock units settle according to the Form 4?
What is Rajeev A. Modi鈥檚 role at Elanco as stated in the filing?
